| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Premier Anti-Aging Co., Ltd. Reports Q2

TOKYO, Mar 12 (Pulse News Wire) – Premier Anti-Aging Co., Ltd. (4934.T) reported consolidated results for Q2 FY2026 (ending July 2026). Revenue was ¥7.34 billion (-13.9% YoY). operating profit was ¥62

View all Premier Anti-Aging Co.,Ltd. disclosures →

TOKYO, Mar 12 (Pulse News Wire) – Premier Anti-Aging Co., Ltd. (4934.T) reported consolidated results for Q2 FY2026 (ending July 2026).

34 billion (-13.9% YoY). 0%).

Net profit attributable to shareholders was ¥445 million (-23.4%). 5 billion with an equity ratio of 67.0%.

For the next fiscal year, the company forecasts 5 billion (+2.1%).

Original Disclosure (PDF)

🟢 Confidence: High

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.

AI-translated content.